.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Attune is stocked at 32 licensed dispensaries across Massachusetts, with the deepest coverage in Brockton, Natick, Webster, Athol, and Ayer. Search by ZIP code or city below to find the closest one.
Market Insights Snapshot
In August 2026, Attune operated as a single-category brand with Topical accounting for 100.0% of sales, while year-over-year sales declined 50.17% and month-over-month sales fell 37.15%. The average price decreased 10.60% year over year to $20.49, aligning with a contraction that is sharper than typical price-driven dips. With Topical at 100.0% share and a rank of 3 in Massachusetts Topical, the brand’s mono-category focus and the dual drop of 50.17% YoY and 37.15% MoM indicate that mix diversification is not offsetting volume pressure, implying a concentration risk rather than a temporary seasonal effect.
The mix shift toward a 100.0% Topical portfolio alongside a 10.60% YoY price reduction and a 50.17% YoY sales decline suggests that price cuts are not converting to incremental volume in August 2026, and the 37.15% MoM contraction compounds that pattern. Holding rank 3 in Massachusetts while posting a 50.17% YoY decline indicates that category-level demand headwinds or limited SKU depth are more influential than pricing levers. The combined signals — 100.0% category reliance, -10.60% pricing, and -37.15% MoM — imply Attune's positioning is anchored to a narrower use case within Topical where promotional elasticity is low, making distribution breadth and formulation differentiation more critical than additional price movement.
Competitive Landscape
Attune is ranked #3 in MA Topical in August 2026, improving 1 rank position year over year from #4, while holding steady versus three months ago at #3 and trailing its April 2026 peak of #2; meanwhile, Treeworks maintained #1 with a 7.1% YoY sales gain and Chill Medicated sits at #2 despite a 21.0% YoY sales decline, whereas Attune’s proximity to the top tightened as Sanctuary Medicinals surged from #10 to #4 on an 86.7% YoY sales jump and Doctor Solomon's held at #5 with a 44.4% YoY sales drop; this pattern implies Attune’s upward rank trajectory is stabilizing near the top tier but future gains depend on outpacing Sanctuary Medicinals’ rapid ascent while capitalizing on Chill Medicated’s contraction.
Notable Products
Muscle Freeze Lotion (100mg THC, 30ml) posted the steepest decline in August 2026 at -55.1% MoM while sliding from outside the lead to rank 2, and CBD/THC 1:1 Muscle Freeze Lotion (75mg CBD, 75mg THC) at rank 1 also fell -41.3% MoM despite holding the top slot. In contrast, CBD/THC 1:2 Muscle Freeze Lotion (30mg CBD, 60mg THC) climbed +43.1% MoM but remained outside the top three at rank 4, and CBD/THC 1:1 Muscle Freeze Lotion (50mg CBD, 50mg THC) rose +18.8% MoM at rank 5. Four of the top five SKUs are 1:1 formulations or close variants, and with total category receipts around $13,580, the pattern implies demand is consolidating around a single flagship while flankers provide limited offset to volatility.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
